Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
The latest announcement is out from Pro Medicus Limited ( (AU:PME) ).
Pro Medicus Limited, through its U.S. subsidiary Visage Imaging, Inc., has secured a $33 million, 9-year contract with the University of Kentucky HealthCare to implement its Visage 7 Enterprise Imaging Platform. This significant deal marks Pro Medicus’s continued expansion into North American academic institutions and underscores the growing trend towards fully cloud-based imaging solutions in the healthcare IT market. The contract involves replacing the existing PACS and archive systems with Visage’s comprehensive suite, and it is expected to enhance diagnostic imaging capabilities across the healthcare system.
More about Pro Medicus Limited
Pro Medicus Limited is a leading healthcare informatics company providing medical imaging software and services to hospitals, imaging centers, and healthcare groups globally. With the acquisition of Visage Imaging in 2009, Pro Medicus has established itself as a global provider of advanced medical imaging solutions through its Visage 7 suite, known for its speed, clinical depth, and scalability, adaptable to both public and private cloud environments.
YTD Price Performance: 1.99%
Average Trading Volume: 426
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $16.42B
Learn more about PME stock on TipRanks’ Stock Analysis page.